Home › Asset managers › ProShares › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal ProShares voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,976 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | ProShares voted | Funds |
|---|---|---|---|---|---|---|
| Innovative Industrial Properties, Inc. | 2026-06-09 | Approval on a non-binding advisory basis of the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 12 |
| Intellia Therapeutics, Inc. | 2026-06-09 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 12 |
| Intellia Therapeutics, Inc. | 2026-06-09 | Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Muna Bhanji, R.Ph. | Director Elections | Board | AGAINST | 12 |
| Interparfums, Inc. | 2025-09-10 | To vote for the advisory resolution to approve executive compensation. | Say-on-Pay | Board | AGAINST | 12 |
| Iovance Biotherapeutics, Inc. | 2026-06-10 | To approve, by non-binding advisory vote, the compensation of our named executive officers; | Say-on-Pay | Board | AGAINST | 12 |
| John B. Sanfilippo & Son, Inc. | 2025-10-29 | Election of Directors: Ellen C. Taaffe | Director Elections | Board | ABSTAIN | 12 |
| John B. Sanfilippo & Son, Inc. | 2025-10-29 | Election of Directors: Mercedes Romero | Director Elections | Board | ABSTAIN | 12 |
| John B. Sanfilippo & Son, Inc. | 2025-10-29 | Election of Directors: Pamela Forbes Lieberman | Director Elections | Board | ABSTAIN | 12 |
| KKR Real Estate Finance Trust Inc. | 2026-04-14 | Election of Directors: Deborah H. McAneny | Director Elections | Board | ABSTAIN | 12 |
| KKR Real Estate Finance Trust Inc. | 2026-04-14 | Election of Directors: Irene M. Esteves | Director Elections | Board | ABSTAIN | 12 |
| KKR Real Estate Finance Trust Inc. | 2026-04-14 | Election of Directors: Jonathan A. Langer | Director Elections | Board | ABSTAIN | 12 |
| KKR Real Estate Finance Trust Inc. | 2026-04-14 | Election of Directors: Terrance R. Ahern | Director Elections | Board | ABSTAIN | 12 |
| Kura Oncology, Inc. | 2026-06-04 | Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan. | Compensation | Board | AGAINST | 12 |
| Kura Oncology, Inc. | 2026-06-04 | Election of three Class III directors for three-year terms: Diane Parks | Director Elections | Board | ABSTAIN | 12 |
| Kura Oncology, Inc. | 2026-06-04 | Election of three Class III directors for three-year terms: Mary T. Szela | Director Elections | Board | ABSTAIN | 12 |
| Kymera Therapeutics, Inc. | 2026-06-24 | To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Bruce Booth, D.Phil. | Director Elections | Board | ABSTAIN | 12 |
| Liquidity Services, Inc. | 2026-02-26 | Approval of an amendment to the Liquidity Services, Inc. Third Amended and Restated 2006 Omnibus Long-Term Incentive Plan to increase the authorized number of shares. | Compensation | Board | AGAINST | 12 |
| Marriott Vacations Worldwide Corporation | 2026-05-15 | Approval of the Second Amended and Restated Marriott Vacations Worldwide Corporation 2020 Equity Incentive Plan. | Compensation | Board | AGAINST | 12 |
| Merchants Bancorp | 2026-05-21 | Election of Directors: Andrew A. Juster | Director Elections | Board | ABSTAIN | 12 |
| Merchants Bancorp | 2026-05-21 | Election of Directors: Anne E. Sellers | Director Elections | Board | ABSTAIN | 12 |
| Merchants Bancorp | 2026-05-21 | Election of Directors: Patrick D. O'Brien | Director Elections | Board | ABSTAIN | 12 |
| Merchants Bancorp | 2026-05-21 | Election of Directors: Tamika D. Catchings | Director Elections | Board | ABSTAIN | 12 |
| Mineralys Therapeutics, Inc. | 2026-05-21 | Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 12 |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSci | Director Elections | Board | ABSTAIN | 12 |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class III nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Timothy Walbert | Director Elections | Board | ABSTAIN | 12 |
| Monarch Casino & Resort, Inc. | 2026-05-27 | Election of Directors: John Farahi | Director Elections | Board | AGAINST | 12 |
| Nurix Therapeutics, Inc. | 2026-05-15 | Election of Class III Directors: Arthur T. Sands, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 12 |
| Nurix Therapeutics, Inc. | 2026-05-15 | Election of Class III Directors: Paul M. Silva | Director Elections | Board | ABSTAIN | 12 |
| Nuvalent, Inc. | 2026-06-16 | Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 12 |
| ORIC Pharmaceuticals, Inc. | 2026-06-18 | To approve the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as amended and restated. | Compensation | Board | AGAINST | 12 |
| OSI Systems, Inc. | 2025-12-11 | Advisory vote to approve the Company's named executive officer compensation for the fiscal year ended June 30, 2025. | Say-on-Pay | Board | AGAINST | 12 |
| OSI Systems, Inc. | 2025-12-11 | Election of Directors: James B. Hawkins | Director Elections | Board | AGAINST | 12 |
| OSI Systems, Inc. | 2025-12-11 | Election of Directors: William F. Ballhaus | Director Elections | Board | AGAINST | 12 |
| Ocular Therapeutix, Inc. | 2026-06-10 | To approve an advisory vote on named executive officer compensation. | Say-on-Pay | Board | AGAINST | 12 |
| Ocular Therapeutix, Inc. | 2026-06-10 | To elect two Class III directors, each to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Pravin U. Dugel, M.D. | Director Elections | Board | ABSTAIN | 12 |
| Omeros Corporation | 2026-06-18 | Approval of the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan. | Compensation | Board | AGAINST | 12 |
| Omeros Corporation | 2026-06-18 | Election of Directors: Diana T. Perkinson, M.D. | Director Elections | Board | AGAINST | 12 |
| Omeros Corporation | 2026-06-18 | Election of Directors: Thomas J. Cable | Director Elections | Board | AGAINST | 12 |
| OmniAb, Inc. | 2026-06-17 | Election of Directors: Jennifer Cochran, Ph.D. | Director Elections | Board | ABSTAIN | 12 |
| OneSpaWorld Holdings Limited | 2026-06-03 | Election of Directors: Andrew R. Heyer | Director Elections | Board | ABSTAIN | 12 |
| PC Connection, Inc. | 2026-05-13 | To elect six directors to serve until the 2027 Annual Meeting of Stockholders: Patricia Gallup | Director Elections | Board | ABSTAIN | 12 |
| PDF Solutions, Inc. | 2026-06-16 | To approve our Eleventh Amended and Restated 2011 Stock Incentive Plan. | Compensation | Board | AGAINST | 12 |
| PennyMac Mortgage Investment Trust | 2026-06-16 | To elect the three Class II Trustees identified in the enclosed Proxy Statement to serve on our Board of Trustees, each for a term expiring at the 2029 Annual Meeting of Shareholders: Preston DuFauchard | Director Elections | Board | AGAINST | 12 |
| Phathom Pharmaceuticals, Inc. | 2026-05-19 | To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Steven Basta | Director Elections | Board | ABSTAIN | 12 |
| Precigen, Inc. | 2026-06-18 | Company Proposal - Election of Directors: Vinita Gupta | Director Elections | Board | AGAINST | 12 |
| Prime Medicine, Inc. | 2026-06-05 | To elect Michael Kelly and David Schenkein, M.D. as Class I Directors: David Schenkein, M.D. | Director Elections | Board | ABSTAIN | 12 |
| Progyny, Inc. | 2026-05-21 | Election of Directors: Cheryl Scott | Director Elections | Board | ABSTAIN | 12 |
| Progyny, Inc. | 2026-05-21 | Election of Directors: Kevin Gordon | Director Elections | Board | ABSTAIN | 12 |
| Progyny, Inc. | 2026-05-21 | Election of Directors: Lloyd Dean | Director Elections | Board | ABSTAIN | 12 |
| REGENXBIO Inc. | 2026-05-29 | Election of three Class II Directors: Jean Bennett, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 12 |
| REGENXBIO Inc. | 2026-05-29 | To approve a stock option exchange for our executive employees. | Compensation | Board | AGAINST | 12 |
| REGENXBIO Inc. | 2026-05-29 | To approve a stock option exchange for our non-executive employees. | Compensation | Board | AGAINST | 12 |
| RXO, Inc. | 2026-05-12 | Approval of an Amendment to the RXO, Inc. 2022 Omnibus Incentive Compensation Plan. | Compensation | Board | AGAINST | 12 |
| Recursion Pharmaceuticals, Inc. | 2026-06-17 | Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. | Say-on-Pay | Board | AGAINST | 12 |
| Recursion Pharmaceuticals, Inc. | 2026-06-17 | Election of Directors: Franziska Michor, Ph.D. | Director Elections | Board | ABSTAIN | 12 |
| Recursion Pharmaceuticals, Inc. | 2026-06-17 | Election of Directors: Najat Khan, Ph.D. | Director Elections | Board | ABSTAIN | 12 |
| Red Rock Resorts, Inc. | 2026-06-04 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 12 |
| Red Rock Resorts, Inc. | 2026-06-04 | Election of 5 director nominees: Frank J. Fertitta III | Director Elections | Board | ABSTAIN | 12 |
| Red Rock Resorts, Inc. | 2026-06-04 | Election of 5 director nominees: James E. Nave, D.V.M. | Director Elections | Board | ABSTAIN | 12 |
| Red Rock Resorts, Inc. | 2026-06-04 | Election of 5 director nominees: Lorenzo J. Fertitta | Director Elections | Board | ABSTAIN | 12 |
| Red Rock Resorts, Inc. | 2026-06-04 | Election of 5 director nominees: Robert A. Cashell, Jr. | Director Elections | Board | ABSTAIN | 12 |
| Red Rock Resorts, Inc. | 2026-06-04 | Election of 5 director nominees: Robert E. Lewis | Director Elections | Board | ABSTAIN | 12 |
| Relay Therapeutics, Inc. | 2026-06-09 | To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Douglas S. Ingram | Director Elections | Board | ABSTAIN | 12 |
| Replimune Group, Inc. | 2025-09-03 | To approve an amendment to Replimune Group, Inc.'s 2018 Omnibus Incentive Compensation Plan (the "Plan Amendment"). | Compensation | Board | AGAINST | 12 |
| Rhythm Pharmaceuticals, Inc. | 2026-06-24 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. | Say-on-Pay | Board | AGAINST | 12 |
| Rigel Pharmaceuticals, Inc. | 2026-05-14 | To approve an amendment to our 2018 Equity Incentive Plan, as amended (the "Amended 2018 Plan"), to add an additional 500,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan. | Compensation | Board | AGAINST | 12 |
| Rocket Pharmaceuticals, Inc. | 2026-05-20 | The approval of the proposed stock option exchange program; and | Compensation | Board | AGAINST | 12 |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Dr. Kennon H. Guglielmo | Director Elections | Board | ABSTAIN | 12 |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Elaine Mendoza | Director Elections | Board | ABSTAIN | 12 |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Raymond J. Chess | Director Elections | Board | ABSTAIN | 12 |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Troy A. Clarke | Director Elections | Board | ABSTAIN | 12 |
| SL Green Realty Corp. | 2026-06-02 | To approve, on a non-binding advisory basis, our executive compensation. | Say-on-Pay | Board | AGAINST | 12 |
| Sabre Corporation | 2026-04-29 | To approve our 2026 Omnibus Incentive Compensation Plan. | Compensation | Board | AGAINST | 12 |
| Safehold Inc. | 2026-05-14 | Approval of proposed amendment to Amended and Restated 2009 Long Term Incentive Plan | Compensation | Board | AGAINST | 12 |
| Sana Biotechnology, Inc. | 2026-06-04 | To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Hans E. Bishop | Director Elections | Board | ABSTAIN | 12 |
| Scholar Rock Holding Corporation | 2026-06-04 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 12 |
| Scholar Rock Holding Corporation | 2026-06-04 | To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: David Hallal | Director Elections | Board | ABSTAIN | 12 |
| Scholastic Corporation | 2025-09-17 | Election of Directors: James W. Barge | Director Elections | Board | ABSTAIN | 12 |
| Schrodinger, Inc. | 2026-06-22 | Approval of an amendment to the Schrodinger, Inc. 2022 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 3,000,000 shares. | Compensation | Board | AGAINST | 12 |
| Schrodinger, Inc. | 2026-06-22 | Election of Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Richard A. Friesner | Director Elections | Board | AGAINST | 12 |
| Sphere Entertainment Co. | 2026-06-10 | Approval of, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 12 |
| Sphere Entertainment Co. | 2026-06-10 | Election of the following nominees as directors: Debra G. Perelman | Director Elections | Board | ABSTAIN | 12 |
| Sphere Entertainment Co. | 2026-06-10 | Election of the following nominees as directors: Joel M. Litvin | Director Elections | Board | ABSTAIN | 12 |
| Sphere Entertainment Co. | 2026-06-10 | Election of the following nominees as directors: John L. Sykes | Director Elections | Board | ABSTAIN | 12 |
| Sphere Entertainment Co. | 2026-06-10 | Election of the following nominees as directors: Joseph J. Lhota | Director Elections | Board | ABSTAIN | 12 |
| Sprinklr, Inc. | 2026-06-11 | To elect one Class II director, to hold office until our Annual Meeting of Stockholders in 2029: Stephen M. Ward, Jr. | Director Elections | Board | ABSTAIN | 12 |
| Stoke Therapeutics, Inc. | 2026-06-03 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 12 |
| Syndax Pharmaceuticals, Inc. | 2026-06-10 | Election of Directors: Pierre Legault | Director Elections | Board | ABSTAIN | 12 |
| Syndax Pharmaceuticals, Inc. | 2026-06-10 | To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 12 |
| Tango Therapeutics, Inc. | 2026-06-04 | Election of Class II Directors: Kanishka Pothula | Director Elections | Board | ABSTAIN | 12 |
| Tango Therapeutics, Inc. | 2026-06-04 | Election of Class II Directors: Mace Rothenberg, M.D. | Director Elections | Board | ABSTAIN | 12 |
| Tango Therapeutics, Inc. | 2026-06-04 | Election of Class II Directors: Malte Peters, M.D. | Director Elections | Board | ABSTAIN | 12 |
| Taysha Gene Therapies, Inc. | 2026-06-01 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 12 |
| Taysha Gene Therapies, Inc. | 2026-06-01 | To elect the Board's Class III Director nominees, Sean P. Nolan and Laura Sepp-Lorenzino, Ph.D. to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Sean P. Nolan | Director Elections | Board | ABSTAIN | 12 |
| The Chefs' Warehouse, Inc. | 2026-05-08 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the 2026 Proxy Statement. | Say-on-Pay | Board | AGAINST | 12 |
| The Vita Coco Company, Inc. | 2026-06-03 | Election of Class II Directors: Kenneth Sadowsky | Director Elections | Board | ABSTAIN | 12 |
| Trevi Therapeutics, Inc. | 2026-06-03 | Election of one Class I director to our Board of Directors, to serve until the 2029 Annual Meeting of Stockholders: Michael Heffernan | Director Elections | Board | ABSTAIN | 12 |
| Twist Bioscience Corporation | 2026-02-05 | Election of Class II Directors: Jan Johannessen | Director Elections | Board | ABSTAIN | 12 |
| Twist Bioscience Corporation | 2026-02-05 | Election of Class II Directors: Keith Crandell | Director Elections | Board | ABSTAIN | 12 |
| Twist Bioscience Corporation | 2026-02-05 | To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation." | Say-on-Pay | Board | AGAINST | 12 |
← Previous Page 6 of 30 Next →
← Back to ProShares 2025-2026 overview
Built 2026-10-04 from SEC Form N-PX filings.